You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2010 or most recent year available
Part (iii) New inpatient clients by primary drug and frequency of use (%)
| Primary drug | Not used in the past month/occasional | Once a week or less | 2–6 times per week | Daily | Frequency known (n) | Frequency unknown | |
|---|---|---|---|---|---|---|---|
| Opioids | 10.3 | 4.5 | 14.8 | 70.3 | 2739 | 181 | |
| Cocaine | 25.8 | 10.1 | 26.6 | 37.5 | 365 | 77 | |
| Stimulants | 14.9 | 13.0 | 37.4 | 34.7 | 1117 | 66 | |
| Cannabis | 11.0 | 9.7 | 20.8 | 58.5 | 1365 | 200 |
Notes:
Percentages are of clients whose frequency of use is known (n)
Only countries reporting data related to primary drug have been included.
The following countries have been included: BE, BG, CZ, DK, IE, GR, FR, CY, HU, NL, AT, RO, SK, FI, SE, HR, TR
See also Table TDI-112 for distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — TDI table — inpatient treatment centres.